Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

CAPR

CAPRICOR THERAPEUTICS, INC.

Pharmaceutical Preparations · SIC 2834CIK 1133869Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$0.0M
Net Income FY2025
$(105.0M)
EPS (Basic, as reported)
$-2.26
Net Margin FY2025
—
ROE FY2025
-34.4%
Total Equity
$306.0M
Shares Out
58M
Business description

CAPRICOR THERAPEUTICS, INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2006–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 4 → 0
Fiscal yearFY2016FY2017FY2018⚑FY2019⚑FY2020⚑FY2021FY2022FY2023FY2024FY2025
Revenue432100325220
Research & development(16)(11)(12)(5)(8)(14)(22)(36)(50)(84)
General & administrative(5)(5)(5)(4)(6)(8)(10)(13)(15)(24)
Total operating expenses(21)(16)(17)(9)(14)(21)(32)(49)(65)(108)
Operating income(17)(13)(15)(8)(14)(21)(30)(24)(43)(108)
Interest expense000—————0(3)
Interest & investment income0000001226
Other income (expense), net(2)1500011223
Pre-tax income————————(40)(105)
Income tax expense————————00
Net income(19)2(15)(8)(14)(20)(29)(22)(40)(105)
EPS — basic($1.01)$0.10——($0.88)($0.87)($1.18)($0.83)($1.15)($2.26)
EPS — diluted($1.01)$0.09($0.52)—($0.88)($0.87)($1.18)($0.83)($1.15)($2.26)
Shares outstanding — basic (M)1923294162325273546
Shares outstanding — diluted (M)1927294162325273546

Showing the latest 10 of 20 fiscal years.

  • ⚑ Weighted-average shares changed ÷7.14 between FY2018 and FY2019 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×4.00 between FY2019 and FY2020 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.44 between FY2020 and FY2021 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.